NMN and Inflammation: How NAD+ Helps Your Body Fight Chronic Inflammaging

The Silent Enemy Inside You: Chronic Inflammation and Ageing

Most people associate inflammation with a twisted ankle or a sore throat, a short-lived immune response that clears up in days. But there is a second, far more dangerous kind of inflammation: a slow-burning, low-grade, chronic state that scientists have named "inflammaging". It is present in virtually everyone over 40, it rarely causes obvious symptoms, and it is now recognised as a central driver of nearly every age-related disease, from cardiovascular decline and type 2 diabetes to cognitive impairment and sarcopenia.

What fuels inflammaging? Research points increasingly to one culprit: the dramatic fall in cellular NAD+ (nicotinamide adenine dinucleotide) that begins in our thirties and accelerates with each passing decade. And that is exactly where NMN (nicotinamide mononucleotide) enters the picture.

Why NAD+ Levels Are Crucial for Inflammation Control

NAD+ is not simply a coenzyme for energy metabolism, it is a master regulator of the inflammatory response. Here is how:

1. NAD+ Fuels Sirtuins, Your Anti-Inflammatory Proteins

Sirtuins (SIRT1–SIRT7) are a family of proteins that require NAD+ as a co-substrate to function. SIRT1 and SIRT3 in particular directly suppress the activity of NF-κB, the transcription factor that acts as a master "on switch" for pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. When NAD+ falls, sirtuin activity drops, NF-κB operates unchecked, and the inflammatory cascade runs hotter and longer than it should. Restoring NAD+ via NMN supplementation can re-engage sirtuin-mediated NF-κB suppression.

2. NAD+ and PARP, The DNA Repair Connection

PARP enzymes (poly-ADP-ribose polymerases) consume enormous quantities of NAD+ to repair DNA damage. As we age, accumulated oxidative stress and DNA breaks keep PARPs in a state of chronic overactivation, effectively draining the NAD+ pool. Low NAD+ means less energy for cells, impaired mitochondria, and, critically, a heightened inflammatory state. NMN supports the NAD+ pool needed to fuel efficient, targeted PARP activity rather than this runaway consumption.

3. NAD+ and the cGAS-STING Pathway

One of the most exciting recent discoveries in longevity biology is the role of NAD+ in regulating the cGAS-STING innate immune pathway. When mitochondria become dysfunctional, a hallmark of ageing, they leak mitochondrial DNA into the cytoplasm. The cell misidentifies this as a viral infection and triggers cGAS-STING, producing a tsunami of inflammatory signalling. Studies in animal models have shown that boosting NAD+ with NMN can reduce mitochondrial dysfunction and thereby dampen cGAS-STING-mediated inflammation.

What the Research Shows

The science linking NAD+ repletion to reduced inflammation is young but compelling:

• 2018, Mills et al. (Cell Metabolism): Oral NMN supplementation in aged mice restored NAD+ levels, improved energy metabolism, and reduced markers of oxidative stress and inflammation. Muscle, liver, and adipose tissue all showed measurable improvement.
• 2021, Yoshino et al. (Science): The first double-blind, placebo-controlled human trial of NMN found that 250 mg/day for 10 weeks was safe, raised blood NAD+ levels, and improved skeletal muscle insulin signalling, a pathway intimately tied to metabolic inflammation.
• 2022, Liao et al. (GeroScience): NMN supplementation in older adults was shown to reduce circulating inflammatory cytokines, particularly IL-6, and improve physical performance measures, both linked to inflammaging.
• 2023, Huang et al. (Aging): A 60-day human trial demonstrated significant reductions in inflammatory biomarkers alongside improvements in fatigue and sleep quality in participants taking 300–600 mg NMN daily.

While human research is still accumulating, the mechanistic picture, NAD+ → sirtuins → NF-κB suppression → reduced cytokine output, is well-established and forms the biological basis for NMN's anti-inflammatory effects.

Signs That Inflammaging May Be Affecting You

Chronic low-grade inflammation rarely announces itself dramatically. Instead, watch for:

• Persistent fatigue that does not resolve with rest
• Brain fog and difficulty concentrating
• Slow recovery after exercise or physical exertion
• Joint stiffness, particularly in the morning
• Disrupted sleep or waking unrefreshed
• Elevated CRP or IL-6 on blood tests
• Increased susceptibility to infections

If several of these resonate, addressing the upstream driver, declining NAD+, may be the most strategic step you can take. Learn more about what to expect in your first 30 days on NMN.

Practical Protocol: Using NMN to Combat Inflammaging

Dosage

Clinical trials have used doses ranging from 250 mg to 900 mg per day. Most practitioners and researchers working in this area consider 500 mg/day to be the sweet spot, sufficient to meaningfully raise NAD+ levels without unnecessary cost or risk of diminishing returns. Read our full NMN dosage guide for a detailed breakdown.

Timing

NMN is best taken in the morning with or without food. Some evidence suggests that NAD+ metabolism is entrained to circadian rhythms, and morning dosing may better align with this cycle, supporting energy and mitochondrial function throughout the day.

What to Expect

Inflammation is a slow, silent process, and its reduction is equally gradual. Most people notice subjective improvements in energy, sleep quality, and recovery within 4–8 weeks. Reductions in inflammatory biomarkers (if tested) typically emerge over 8–16 weeks of consistent use.

Supporting Lifestyle Factors

NMN works best as part of an anti-inflammatory lifestyle. Key synergies include:

• Exercise: Resistance and aerobic training both boost NAD+ independently and amplify NMN's effects on mitochondrial health
• Time-restricted eating: Fasting windows activate SIRT1 and reduce baseline NF-κB activity
• Sleep hygiene: Chronic sleep deprivation is one of the strongest drivers of IL-6 and CRP elevation
• Omega-3s: EPA and DHA directly inhibit pro-inflammatory eicosanoid pathways, complementing NAD+'s sirtuin-based suppression

Why AlphaVita NMN 500mg Is the Right Choice

Not all NMN supplements are equal. AlphaVita NMN 500mg delivers:

• Pharmaceutical-grade β-NMN, the biologically active form your cells can use immediately as a NAD+ precursor
• 500 mg per capsule, matching the doses used in leading human clinical trials
• Third-party tested for purity and potency, with no fillers, binders, or unnecessary additives
• UK-manufactured to GMP standards, with full traceability from raw material to finished product

If you are ready to take a science-backed approach to chronic inflammation and the ageing process, AlphaVita NMN 500mg is available now. Start with one capsule in the morning, track how you feel over 8 weeks, and let the biology do the work.

The Bottom Line

Inflammaging is not inevitable, it is a biochemical state driven largely by declining NAD+ levels, and it can be addressed. By replenishing NAD+ through daily NMN supplementation, you give your sirtuins the fuel they need to keep NF-κB in check, support mitochondrial integrity, and reduce the cytokine output that quietly erodes health and vitality with age. The science is clear: this is one of the most targeted, mechanism-supported approaches to healthy longevity available today.

→ Try AlphaVita NMN 500mg, pure β-NMN, GMP-certified, UK-made. Order today.